Paying users zone. Data is covered by 
.
Get to Regeneron Pharmaceuticals Inc. for $15.99, or
get to entire website for at least 3 months from $49.99.
Long-term Debt and Solvency Analysis
Difficulty: Beginner
Solvency ratios also known as long-term debt ratios measure a company’s ability to meet long-term obligations.
Ratios (Summary)
Regeneron Pharmaceuticals Inc., debt and solvency ratios
| Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | ||
|---|---|---|---|---|---|---|
| Debt to equity | |
|
|
|
|
|
| Debt to capital | |
|
|
|
|
|
| Interest coverage | |
|
|
|
|
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
| Ratio | Description | The company |
|---|---|---|
| Debt-to-equity ratio | A solvency ratio calculated as total debt divided by total shareholders’ equity. | Regeneron Pharmaceuticals Inc.’s debt-to-equity ratio deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level. |
| Debt-to-capital ratio | A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. | Regeneron Pharmaceuticals Inc.’s debt-to-capital ratio deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level. |
| Ratio | Description | The company |
|---|---|---|
| Interest coverage ratio | A solvency ratio calculated as EBIT divided by interest payments. | Regeneron Pharmaceuticals Inc.’s interest coverage ratio deteriorated from 2016 to 2017 but then slightly improved from 2017 to 2018. |
Debt to Equity
Regeneron Pharmaceuticals Inc., debt to equity calculation, comparison to benchmarks
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
2018 Calculations
1 Debt to equity = Total debt ÷ Stockholders’ equity
= ÷ =
| Ratio | Description | The company |
|---|---|---|
| Debt-to-equity ratio | A solvency ratio calculated as total debt divided by total shareholders’ equity. | Regeneron Pharmaceuticals Inc.’s debt-to-equity ratio deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level. |
Debt to Capital
Regeneron Pharmaceuticals Inc., debt to capital calculation, comparison to benchmarks
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
2018 Calculations
1 Debt to capital = Total debt ÷ Total capital
= ÷ =
| Ratio | Description | The company |
|---|---|---|
| Debt-to-capital ratio | A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. | Regeneron Pharmaceuticals Inc.’s debt-to-capital ratio deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level. |
Interest Coverage
Regeneron Pharmaceuticals Inc., interest coverage calculation, comparison to benchmarks
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
2018 Calculations
1 Interest coverage = EBIT ÷ Interest expense
= ÷ =
| Ratio | Description | The company |
|---|---|---|
| Interest coverage ratio | A solvency ratio calculated as EBIT divided by interest payments. | Regeneron Pharmaceuticals Inc.’s interest coverage ratio deteriorated from 2016 to 2017 but then slightly improved from 2017 to 2018. |